Zepp Health Corporation
ZEPP · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $1 | $1 | $1 | $2 |
| + Debt | $1 | $1 | $2 | $1 |
| Enterprise Value | $1 | $1 | $1 | $0 |
| Revenue | $1 | $2 | $4 | $6 |
| % Growth | -46.6% | -40.8% | -31.7% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 38.5% | 26.2% | 19.4% | 20.9% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -25.9% | -5.7% | -6.2% | 3.3% |
| Net Income | -$1 | -$0 | -$0 | $0 |
| % Margin | -41.6% | -8.8% | -7% | 2.2% |
| EPS Diluted | -136.64 | -7.84 | -10.84 | 5.24 |
| % Growth | -1,642.9% | 27.7% | -306.9% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |